Accelerate Diagnostics, Inc. (AXDX)
NASDAQ: AXDX · Real-Time Price · USD
1.121
+0.046 (4.28%)
Dec 26, 2024, 2:36 PM EST - Market open
Accelerate Diagnostics Employees
Accelerate Diagnostics had 134 employees as of December 31, 2023. The number of employees decreased by 45 or -25.14% compared to the previous year.
Employees
134
Change (1Y)
-45
Growth (1Y)
-25.14%
Revenue / Employee
$88,873
Profits / Employee
-$398,910
Market Cap
28.07M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Enlivex Therapeutics | 71 |
Curis | 49 |
LAVA Therapeutics | 37 |
Sol-Gel Technologies | 36 |
Cognition Therapeutics | 28 |
Daré Bioscience | 26 |
Longeveron | 24 |
Lipocine | 17 |
AXDX News
- 6 weeks ago - Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Accelerate Diagnostics Reports Third Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results - PRNewsWire
- 3 months ago - Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System - PRNewsWire
- 4 months ago - Accelerate Diagnostics, Inc. (AXDX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Accelerate Diagnostics Reports Second Quarter 2024 Financial Results - PRNewsWire
- 5 months ago - Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial - PRNewsWire
- 5 months ago - Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results - PRNewsWire